Hepatocellular Carcinoma Kinome Atlas As An Employable Instrumented Personalized Medicine
Kipp, Z. A.; Bates, E. A.; Martinez, G. J.; Lee, W.-H.; Pauss, S. N.; Hinds, T. D.
Show abstract
Liver cancer ranks high among cancer death rates and is resistant to most therapies. Studies of protein functionality are limited in patients with hepatocellular carcinoma (HCC). Here, we constructed an HCC kinome activity atlas and used it to develop personalized medicine technology applicable to profiling protein functionality. We used PamGene PamStation kinome technology that quantified protein kinase activity across hundreds of pathways for HCC tumor and non-tumor regions from both sexes. According to our bioinformatic analyses of kinases, ABL was the most active for men and women with HCC. Next, we employed three ABL inhibitors while running the PamStation, which revealed discernible alterations in ABL and other pathways. We deconvoluted over 500 kinase pathways and generated a personalized medicine (PerMed) score delineating activity levels; results were substantiated in five human hepatocyte cancer cell lines. Our work establishes an HCC kinome atlas and demonstrates PamStations potential for precision medicine applications.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Selective Impact of ALK and MELK Inhibition on ERα Stability and Cell Proliferation in Cell Lines Representing Distinct Molecular Phenotypes of Breast Cancer 93%
- Deeper insights into long-term survival heterogeneity of Pancreatic Ductal Adenocarcinoma (PDAC) patients using integrative individual- and group-level transcriptome network analyses 92%
- Targeting the translational machinery in gastrointestinal stromal tumors (GIST) - a new therapeutic vulnerability 92%
Similar papers in this journal
- Rapid Identification and Phenotyping of Nonalcoholic Fatty Liver Disease Patients Using an Automated Algorithmic Approach in Diverse, Urban Healthcare Systems 90%
- HMGB1 correlates with severity and death of COVID-19 patients 88%
- A Framework to Quantify Disparities in Pharmacogenomic Treatment Concordance and Drug Response Outcomes 88%
Similar papers in this journal
- A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer 92%
- A subset of CB002 xanthine analogues bypass p53-signaling to restore a p53 transcriptome and target an S-phase cell cycle checkpoint in tumors with mutated-p53 92%
- Long-read single-cell sequencing reveals expressions of hypermutation clusters of isoforms in human liver cancer cells 92%
Similar papers in this journal
- Olaparib and Enzalutamide synergistically suppress HCC progression via the AR-mediated miR-146a-5p/BRCA1 signaling 93%
- Increased susceptibility to ischemia causes exacerbated response to microinjuries in the cirrhotic liver 90%
- Basal-like and Classical cells coexistence in pancreatic cancer revealed by single cell analysis 89%
Similar papers in this journal
- Multiscale Analysis And Validation Of Effective Drug Combinations Targeting Driver Kras Mutations In Non-Small Cell Lung Cancer 92%
- Optimized transcriptional signature for evaluation of MEK/ERK pathway baseline activity and long-term modulations in ovarian cancer 92%
- Data independent acquisition mass spectrometry (DIA-MS) analysis of FFPE rectal cancer samples offers in depth proteomics characterization of response to neoadjuvant chemoradiotherapy 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.